Pharmaceutical Pricing in Germany: How Is Value Determined within the Scope of AMNOG?

Volume: 20, Issue: 7, Pages: 927 - 935
Published: Jul 1, 2017
Abstract
ObjectivesTo analyze how value is determined within the scope of the German Pharmaceutical Restructuring Act, which came into effect in 2011.MethodsUsing data from all pharmaceuticals that had undergone assessment, appraisal, and price negotiations in Germany before June 30, 2016, we applied generalized linear model regression to analyze the impact of added benefit on the difference between negotiated prices and the prices of comparators. Data...
Paper Details
Title
Pharmaceutical Pricing in Germany: How Is Value Determined within the Scope of AMNOG?
Published Date
Jul 1, 2017
Volume
20
Issue
7
Pages
927 - 935
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.